ZA902627B - Substituted 1,8-naphthyridines - Google Patents

Substituted 1,8-naphthyridines

Info

Publication number
ZA902627B
ZA902627B ZA902627A ZA902627A ZA902627B ZA 902627 B ZA902627 B ZA 902627B ZA 902627 A ZA902627 A ZA 902627A ZA 902627 A ZA902627 A ZA 902627A ZA 902627 B ZA902627 B ZA 902627B
Authority
ZA
South Africa
Prior art keywords
naphthyridines
substituted
appropriate
cyclisation
medicaments
Prior art date
Application number
ZA902627A
Other languages
English (en)
Inventor
Walter Huebsch
Huebsch Walter
Rolf Angerbauer
Angerbauer Rolf
Peter Fey
Fey Peter
Thomas Philipps
Philipps Thomas
Hilmar Bischoff
Bischoff Hilmar
Dieter Petzinna
Petzinna Dieter
Delf Schmidt
Schmidt Delf
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA902627B publication Critical patent/ZA902627B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA902627A 1989-04-06 1990-04-05 Substituted 1,8-naphthyridines ZA902627B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3911064A DE3911064A1 (de) 1989-04-06 1989-04-06 Substituierte 1,8-naphthyridine

Publications (1)

Publication Number Publication Date
ZA902627B true ZA902627B (en) 1991-01-30

Family

ID=6377950

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902627A ZA902627B (en) 1989-04-06 1990-04-05 Substituted 1,8-naphthyridines

Country Status (14)

Country Link
US (1) US5034399A (da)
EP (1) EP0391185B1 (da)
JP (1) JPH02290876A (da)
KR (1) KR900016207A (da)
AT (1) ATE99310T1 (da)
AU (1) AU622010B2 (da)
CA (1) CA2013783A1 (da)
DE (2) DE3911064A1 (da)
DK (1) DK0391185T3 (da)
ES (1) ES2062145T3 (da)
HU (1) HUT53904A (da)
IL (1) IL93988A0 (da)
PT (1) PT93662A (da)
ZA (1) ZA902627B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4022414A1 (de) * 1990-07-13 1992-01-16 Bayer Ag Substituierte pyrrolo-pyridine
EP0497226B1 (en) * 1991-01-29 1999-08-25 Mitsubishi Jukogyo Kabushiki Kaisha Method for producing methanol by use of nuclear heat and power generating plant
DE4405712A1 (de) * 1994-02-23 1995-08-24 Basf Ag Substituierte Naphthyridine und deren Verwendung
DE19627431A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Heterocyclisch kondensierte Pyridine
AR008789A1 (es) 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
WO2003064392A1 (en) * 2002-01-31 2003-08-07 Novartis Ag Process for the manufacture of hmg-coa reductase inhibitors
EP1596860A4 (en) * 2003-02-14 2009-05-27 Smithkline Beecham Corp NEW CONNECTIONS
US7420059B2 (en) * 2003-11-20 2008-09-02 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
DE602005023347D1 (de) 2004-12-23 2010-10-14 Hui Yao Pyrimidinonverbindungen, ihre herstellung und ihre verwendung
US20100093738A1 (en) * 2006-10-06 2010-04-15 Basf Se Fungicidal Compounds and Fungicidal Compositions
US20210008084A1 (en) 2017-10-16 2021-01-14 Tsinghua University Mevalonate pathway inhibitor and pharmaceutical composition thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA988522A (en) * 1972-05-05 1976-05-04 Haydn W.R. Williams 1,8-naphthyridine compounds
GR69216B (da) * 1979-06-15 1982-05-07 Merck & Co Inc
HU204253B (en) * 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
PH24782A (en) * 1985-10-24 1990-10-30 Sankyo Co Composition containing a penem or carbapenem antibiotic and the use of the same
JPH07116187B2 (ja) * 1987-07-22 1995-12-13 シェリング・コーポレーション 二環式化合物、それらを薬剤として使用すること、それらの製法、およびそれらの製造に有用な中間体
US4761419A (en) * 1987-12-07 1988-08-02 Warner-Lambert Company 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
DE3825611A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte annellierte pyrrole, verfahren sowie zwischenprodukte zu ihrer herstellung, und ihre verwendung in arzneimitteln, insbesondere als hmg-coa-reduktase-inhibitoren
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives

Also Published As

Publication number Publication date
ES2062145T3 (es) 1994-12-16
HUT53904A (en) 1990-12-28
EP0391185A1 (de) 1990-10-10
AU622010B2 (en) 1992-03-26
IL93988A0 (en) 1991-01-31
AU5254290A (en) 1990-10-11
DE59003994D1 (de) 1994-02-10
DK0391185T3 (da) 1994-04-11
HU902098D0 (en) 1990-07-28
ATE99310T1 (de) 1994-01-15
JPH02290876A (ja) 1990-11-30
CA2013783A1 (en) 1990-10-06
EP0391185B1 (de) 1993-12-29
DE3911064A1 (de) 1990-10-11
US5034399A (en) 1991-07-23
PT93662A (pt) 1990-11-20
KR900016207A (ko) 1990-11-12

Similar Documents

Publication Publication Date Title
DE69202060D1 (de) OPTISCH AKTIVES 5H-PYRROLO[3,4-b]PYRAZINDERIVAT, SEINE HERSTELLUNG UND PHARMAZEUTISCHE ZUBEREITUNGEN DIE ES ENTHALTEN.
MA21834A1 (fr) Complement de vitamines et de mineraux et boissons nutritves les contenant .
GR3005447T3 (da)
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
GR3007385T3 (da)
AU7573087A (en) Substituted hydrazones, process for the preparation and their use as pesticide
ZA902627B (en) Substituted 1,8-naphthyridines
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
AU2861389A (en) Disubstituted pyridines
IE900058L (en) New substituted pyrido(2,3-d)pyrimidines
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
CA2003213A1 (en) Antimycotically active cyclopropyl-substituted azolylmethylcarbinols
ZA902165B (en) Substituted biphenyls
AU7025087A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base
AU638082B2 (en) Thiazolyl-5-carbonamide derivatives, the preparation thereof composition containing them and their use against microorganisms
HUT46881A (en) Herbicides comprising cyclohexane-1,3,5-triones as active ingredient and process for producing the active ingredients
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
AU6157190A (en) Substituted n-heterocycles, their preparation and their use
DE58902178D1 (en) Isomere formyl-trimethylbicyclo(2,2,2)oct-7-ene.
AU4820990A (en) Substituted 3-azabicyclo(3.1.1)heptanes, their production and use
ZA88664B (en) 2-imino-1,3-dithietanes,their preparation and use as pesticides
SG13094G (en) Stabilization of the preservative thiomersal in ophthalmic pharmaceutical compositions.
DE3680540D1 (de) Vorrichtung zur herstellung und zur verabreichung von getraenken.
AU7054991A (en) 4-azatricyclo{2.2.1.02,6}heptanes and pharmaceutical compositions